| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000048701.86621.D0 |
| P698 | PubMed publication ID | 12524227 |
| P2093 | author name string | Ermanno Gherardi | |
| Jeanette M Wood | |||
| Shiladitya Sengupta | |||
| Ram Sasisekharan | |||
| Lynda A Sellers | |||
| Tai-Ping D Fan | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| angiogenesis | Q539568 | ||
| P304 | page(s) | 69-75 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor | |
| P478 | volume | 23 |
| Q42819421 | A central role for hepatocyte growth factor in adipose tissue angiogenesis |
| Q24546366 | Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity |
| Q47303095 | Activated HGF-c-Met Axis in Head and Neck Cancer |
| Q36800040 | Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis |
| Q36035683 | Angiogenesis and organ transplantation |
| Q37733001 | Angiogenic sprouting is regulated by endothelial cell expression of Slug |
| Q36246052 | Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. |
| Q36160994 | Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review |
| Q39684133 | Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth. |
| Q41490164 | Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain |
| Q28728494 | Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle |
| Q34068511 | Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. |
| Q42429806 | Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments |
| Q41891314 | Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects |
| Q35158221 | Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors |
| Q57791826 | Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression |
| Q35218706 | Gene-based therapeutic angiogenesis |
| Q41834933 | HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion |
| Q38154506 | Heparan sulfate in angiogenesis: a target for therapy |
| Q30426536 | Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway |
| Q34500778 | Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway |
| Q33990421 | Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells |
| Q35070805 | Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis |
| Q34567943 | Hierarchical mechanochemical switches in angiostatin |
| Q36414376 | Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF. |
| Q45061127 | Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells |
| Q27675641 | LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models |
| Q37421053 | MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. |
| Q35831676 | Obesity, adipocytokines, and insulin resistance in breast cancer |
| Q36419956 | Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype |
| Q54361030 | Recombinant hepatocyte growth factor treatment in a canine model of congenital liver hypoplasia. |
| Q39713444 | Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation |
| Q24683896 | Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis |
| Q37608433 | Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization |
| Q35815609 | TGFβ signalling pathway regulates angiogenesis by endothelial cells, in an adipose-derived stromal cell/endothelial cell co-culture 3D gel model |
| Q33768073 | The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells. |
| Q35170435 | The basement membrane matrix in malignancy |
| Q44304351 | The mechanism of gefitinib resistance induced by hepatocyte growth factor in sensitive non-small cell lung cancer cells in vitro |
| Q36395707 | The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing |
| Q36915616 | Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis |
| Q90173116 | Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma |
| Q24672387 | Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells |
| Q45769997 | c-Met signaling pathway participating in the gefitinib resistance of different gene types of non-small cell lung cancer cells induced by HGF in vitro |
Search more.